Sheldrick et al. observed that NT3, as well as BDNF production, was elevated in different regions of the brains of individuals medicated for depression with selective serotonin reuptake inhibitors or tricyclic antidepressants compared to their counterparts whose depression was not managed pharmacologically [31]. Here, BDNF is linked to depressive symptom measurement.